| The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein F Helle, A Goffard, V Morel, G Duverlie, J McKeating, ZY Keck, S Foung, ... Journal of virology 81 (15), 8101-8111, 2007 | 275 | 2007 |
| Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions F Helle, G Vieyres, L Elkrief, CI Popescu, C Wychowski, V Descamps, ... Journal of virology 84 (22), 11905-11915, 2010 | 263 | 2010 |
| Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus Y Rouillé, F Helle, D Delgrange, P Roingeard, C Voisset, E Blanchard, ... Journal of virology 80 (6), 2832-2841, 2006 | 246 | 2006 |
| Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans F Helle, C Wychowski, N Vu-Dac, KR Gustafson, C Voisset, J Dubuisson Journal of Biological Chemistry 281 (35), 25177-25183, 2006 | 234 | 2006 |
| Early steps of the hepatitis C virus life cycle J Dubuisson, F Helle, L Cocquerel Cellular microbiology 10 (4), 821-827, 2008 | 198 | 2008 |
| Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein C Montpellier, C Wychowski, IM Sayed, JC Meunier, JM Saliou, ... Gastroenterology 154 (1), 211-223. e8, 2018 | 192 | 2018 |
| Hepatitis C virus entry into host cells F Helle, J Dubuisson Cellular and Molecular Life Sciences 65, 100-112, 2008 | 183 | 2008 |
| Anti-spike, anti-nucleocapsid and neutralizing antibodies in SARS-CoV-2 inpatients and asymptomatic individuals E Brochot, B Demey, A Touzé, S Belouzard, J Dubuisson, JL Schmit, ... Frontiers in microbiology 11, 584251, 2020 | 164 | 2020 |
| The CD81 partner EWI-2wint inhibits hepatitis C virus entry V Rocha-Perugini, C Montpellier, D Delgrange, C Wychowski, F Helle, ... PloS one 3 (4), e1866, 2008 | 160 | 2008 |
| The hepatitis C virus glycan shield and evasion of the humoral immune response F Helle, G Duverlie, J Dubuisson Viruses 3 (10), 1909, 2011 | 122 | 2011 |
| Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial L Alvarez‐Lajonchere, NH Shoukry, B Gra, Y Amador‐Cañizares, F Helle, ... Journal of viral hepatitis 16 (3), 156-167, 2009 | 121 | 2009 |
| Biology of the BKPyV: an update F Helle, E Brochot, L Handala, E Martin, S Castelain, C Francois, ... Viruses 9 (11), 327, 2017 | 107 | 2017 |
| Initiation of hepatitis C virus infection requires the dynamic microtubule network: role of the viral nucleocapsid protein F Roohvand, P Maillard, JP Lavergne, S Boulant, M Walic, U Andréo, ... Journal of Biological Chemistry 284 (20), 13778-13791, 2009 | 105 | 2009 |
| Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry C Voisset, M Lavie, F Helle, AO De Beeck, A Bilheu, J Bertrand‐Michel, ... Cellular microbiology 10 (3), 606-617, 2008 | 103 | 2008 |
| Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review B Demey, C Tinez, C Francois, F Helle, G Choukroun, G Duverlie, ... Journal of clinical virology 109, 6-12, 2018 | 93 | 2018 |
| Genetic recombination of the hepatitis C virus: clinical implications V Morel, C Fournier, C Francois, E Brochot, F Helle, G Duverlie, ... Journal of viral hepatitis 18 (2), 77-83, 2011 | 89 | 2011 |
| Simeprevir for the treatment of hepatitis C virus infection L Izquierdo, F Helle, C François, S Castelain, G Duverlie, E Brochot Pharmacogenomics and personalized medicine, 241-249, 2014 | 71 | 2014 |
| Disulfide bonds in hepatitis C virus glycoprotein E1 control the assembly and entry functions of E2 glycoprotein A Wahid, F Helle, V Descamps, G Duverlie, F Penin, J Dubuisson Journal of virology 87 (3), 1605-1617, 2013 | 71 | 2013 |
| Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection S Bocchetta, P Maillard, M Yamamoto, C Gondeau, F Douam, S Lebreton, ... PloS one 9 (3), e92140, 2014 | 53 | 2014 |
| A simple and reliable strategy for BK virus subtyping and subgrouping V Morel, E Martin, C François, F Helle, J Faucher, T Mourez, G Choukroun, ... Journal of clinical microbiology 55 (4), 1177-1185, 2017 | 52 | 2017 |
Cécile VoissetInserm Researcher, School of Medicine, Brest, France在 univ-brest.fr 的电子邮件经过验证
